Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P714: Efficacy and safety of infliximab retreatment in luminal Crohn’s disease: a multi-centre, prospective, observational cohort (REGAIN) study

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Boschetti*1, B. Pariente2, D. Laharie3, X. Roblin4, C. Gilletta5, A. Aubourg6, A. Bourreille7, C. Zallot8, X. Hebuterne9, A. Buisson10, J-C. Grimaud11, Y. Bouhnik12, M. Allez13, R. Altwegg14, S. Viennot15, L. Vuitton16, F. Carbonnel17, M. Nachury2, S. Paul18, J. Lambert19, L. Peyrin-Biroulet8, Getaid1

1Lyon-Sud Hospital, Gastroenterology, Pierre Bénite, France, 2CHRU Lille, Gastroenterology, Lille, France, 3CHU Bordeaux, Gastroenterology, Bordeaux, France, 4CHU Saint-Etienne, Gastroenterology, Saint-Etienne, France, 5CHU Toulouse, Gastroenterology, Toulouse, France, 6CHU Tours, Gastroenterology, Tours, France, 7CHU Nantes, Gastroenterology, Nantes, France, 8CHU Nancy, Gastroenterology, Nancy, France, 9CHU Nice, Gastroenterology, Nice, France, 10CHU Clermont-Ferrand, Gastroenterology, Clermont-Ferrand, France, 11Assistance Publique-Hôpitaux de Marseille, Gastroenterology, Marseille, France, 12Beaujon Hospital, Gastroenterology, Paris, France, 13Saint-Louis Hospital, Gastroenterology, Paris, France, 14CHU Montpellier, Gastroenterology, Montpellier, France, 15CHU Caen, Gastroenterology, Caen, France, 16CHU Besançon, Gastroenterology, Besançon, France, 17Bicêtre Hospital, Gastroenterology, Le Kremlin-Bicêtre, France, 18CHU Saint-Etienne, Immunology, Saint-Etienne, France, 19Paris Diderot University, Paris, France

P715: Real-world tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Lair-Mehiri*1, C. Stefanescu1, T. Vaysse2, D. Laharie3, X. Roblin4, I. Rosa5, X. Treton1, V. Abitbol6, A. Amiot7, G. Bouguen8, N. Dib9, M. Fumery10, B. Pariente11, F. Carbonnel2, L. Peryn-Biroulet12, M. Simon13, S. Viennot14, Y. Bouhnik1

1APHP-Hôpital Beaujon, Department of Gastroenterology, Clichy, France, 2APHP-Hôpital Bicêtre, Department of Gastroenterology, Le Kremlin Bicêtre, France, 3Bordeaux University Hospital, Department of Gastroenterology, Bordeaux, France, 4Saint-Etienne University Hospital, Department of Gastroenterology, Saint Etienne, France, 5Intercommunal Creteil Hospital Center, Department of Gastroenterology, Créteil, France, 6AP-HP, Cochin Hospital, Department of Gastroenterology, Paris, France, 7AP-HP, Hôpital Henri Mondor, Department of Gastroenterology, Créteil, France, 8Rennes University Hospital, Department of Gastroenterology, Rennes, France, 9Angers University Hospital, Department of Gastroenterology, Angers, France, 10Amiens University Hospital, Department of Gastroenterology, Amiens, France, 11Lille University Hospital, Department of Gastroenterology, Lille, France, 12Nancy University Hospital, Department of Gastroenterology, Nancy, France, 13Institut Mutualiste Montsouris, Department of Gastroenterology, Paris, France, 14Caen University Hospital, Department of Gastroenterology, Caen, France

P716: The use of tacrolimus in patients with ulcerative colitis resistant to standard medical therapy

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Shafi*1, A. Bedir2, L. Medcalf1, G. Chung-Faye1, B. Hope1, P. Dubois1, B. Hayee1, B. Vadamalayan1, A. J. Kent1

1King's College Hospital, London, UK, 2Basildon and Thurrock University Hospital, Essex, UK

P717: The use of combination biologic therapy in inflammatory bowel disease: A single tertiary-centre experience

ECCO '19 Copenhagen

Year: 2019
Authors:

N. Panaccione*1, K. Novak1, C. Seow1, S. Devlin1, C. Lu1, J. Heatherington1, M-L. Martin1, G. Kaplan1, R. Panaccione1

1University of Calgary, Medicine, Calgary, Canada

P718: Risk of tuberculosis in patients with inflammatory bowel disease receiving biologics using two interferon-γ release assays as monitoring

ECCO '19 Copenhagen

Year: 2019
Authors:

R. de Francisco*1,2, M. Arias-Guillén3, A. Castaño-García1, I. Pérez-Martínez1, J. J. Palacios4, V. Rolle-Sóñora2, S. Martínez-González1, V. Jiménez-Beltrán1, N. Rodríguez-Ferreiro1, P. Flórez-Díez1, A. Suárez1,2, S. Riestra1,2

1Hospital Universitario Central de Asturias, Gastroenterology, Oviedo, Spain, 2Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain, 3Hospital Universitario Central de Asturias, Respiratory, Oviedo, Spain, 4Hospital Universitario Central de Asturias, Microbiology, Oviedo, Spain

P719: Update of a network meta-analysis of efficacy and safety of different intravenous iron compounds in patients with IBD and anaemia

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Aksan*1,2, H. Işık2, H. H. Radeke1,3, A. Dignass4, J. Stein1,5

1Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, 2Hacettepe University, Ankara, Turkey, 3Pharmazentrum Frankfurt, Hospital of the Goethe University, Institute of Pharmacology and Toxicology, Frankfurt/Main, Germany, 4Agaplesion Markuskrankenhaus, Frankfurt/Main, Germany, 5DGD Clinics Sachsenhausen, Frankfurt/Main, Germany

P720: Efficacy of exclusive enteral nutrition for induction and partial enteral nutrition for maintenance of remission in newly diagnosed paediatric and adolescent Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Ikeda*1, T. Ogashiwa1, Y. Nakamori1, T. Mitsui1, K. Chida1, Y. Hashimoto1, Y. Tamura1, S. Maeda2, H. Kimura1, R. Kunisaki1

1Yokohama City University Medical Centre, Inflammatory Bowel Disease Center, Yokohama, Japan, 2Yokohama City University Graduate School of Medicine, Department of Gastroenterology, Yokohama, Japan

P721: Effect of thalidomide on clinical remission in adult with refractory crohn disease, a multicentre, randomised, double-blind clinical trial

ECCO '19 Copenhagen

Year: 2019
Authors:

X. Peng*1, M. Zhi1, Q. Cao2, P. Hu1, X. Gao1

1The sixth hospital affiliated to sun yat-sen university, Gastroenterology dept., Guangzhou, China, 2Run run shaw hospital affiliated of zhejiang university, Gastroenterology dept., Hangzhou, China

P722: Results of the STAR study: management of ulcerative colitis in private practice in france, in the first years following diagnosis

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Bourreille*1, S. Nancey2, A. Attar3, H. Sokol4, L. Peyrin-Biroulet5, Y. Bouhnik6, X. Roblin7, G. Bonnaud8

1Hospital Hôtel-Dieu, Gastroenterology &Nutrition, Nantes, France, 2Centre Hospitalier LYON-SUD, Gastroenterology &Hepatology, Pierre-Bénite, Lyon, France, 3Private practice, Paris, France, 4Saint-Antoine Hospital, Gastroenterology and Nutrition, Paris, France, 5CHU of Nancy - Hôpitaux du Brabois, Gastroenterology and Hepatology, Vandoeuvre-lès-Nancy, France, 6Beaujon Hospital, Gastroenterology and Nutrition, Clichy, France, 7CHU 42 Hôpital Nord, Gastroenterology, St Priest en Jarez, Saint-Etienne, France, 8Private practice, Gastroenterology, Hepatology and Proctology, Colomiers, France

P723: Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with iron isomaltoside or ferric carboxymaltose: results of a prospective cluster randomised cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

T. E. Detlie*1,2, J. C. Lindstrøm3, M. E. Jahnsen1, E. Finnes4, H. Zoller5, B. Moum4,6, J. Jahnsen1,2

1Akershus University Hospital, Department of gastroenterology, Lørenskog, Norway, 2University of Oslo, Institute of Clinical Medicine, Oslo, Norway, 3Akershus University Hospital, Health Services Research Unit, Lørenskog, Norway, 4Oslo University Hospital, Department of Gastroenterology, Oslo, Norway, 5Medical University of Innsbruck, Department of Medicine II, Gastroenterology and Hepatology, Innsbruck, Austria, 6Univeristy of Oslo, Institute of Clinical Medicine, Oslo, Norway

P724: Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Card*1, R. Ungaro2, F. Bhayat3, A. Blake3, G. Hantsbarger3, S. Travis4

1University of Nottingham, Faculty of Medicine and Health Sciences, Nottingham, UK, 2Icahn School of Medicine at Mount Sinai, Division of Gastroenterology, New York, USA, 3Takeda Pharmaceuticals International Co., Cambridge, USA, 4Oxford University Hospitals NHS Foundation Trust, Translational Gastroenterology Unit, Oxford, UK

P725: A prospective study of planned switch from Infliximab originator remicade to biosimilar inflectra: a multi-centre Irish experience

ECCO '19 Copenhagen

Year: 2019
Authors:

N. McGettigan*1, C. Mc Shane2, O. Mc Carthy1, A. Keogh1, D. Kevans2, E. Slattery1

1Galway University Hospital, Gastroenterology, Galway, Ireland, 2St James Hospital, Gastroenterology, Dublin, Ireland

P726: Trough levels of infliximab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn’s disease on infliximab maintenance therapy

ECCO '19 Copenhagen

Year: 2019
Authors:

E. H. Oh*1, A-R. Yoon2, S. H. Park3, J. Kim1, N. Ham1, E. M. Song1, S. W. Hwang1,2, S. H. Park1,2, D-H. Yang1, J-S. Byeon1, S-J. Myung1, S-K. Yang1,2, B. D. Ye1,2

1Asan Medical Center, Gastroenterology, Seoul, South Korea, 2Asan Medical Center, Inflammatory Bowel Disease Center, Seoul, South Korea, 3Asan Medical Center, Radiology, Seoul, South Korea

P727: Quality of life and disease activity in children and adolescents with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Aloi*1, E. Carloni1, F. Palmacci1, M. Distante1, G. Catassi1, G. D'Arcangelo1, S. Cucchiara1, AMICI Italian IBD Association1

1Sapienza University of Rome, Department of Pediatrics, Pediatric Gastroenterology Unit, Rome, Italy

P728: Effectiveness and quality of life (QoL) of Ustekinumab (UST) therapy in a Real-world Setting in Germany – First Results of the RUN-CD Study

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Bokemeyer*1,2, S. Plachta-Danielzik3, N. Teich4, W. Mohl5, M. Hoffstadt6, A. Schweitzer7, M. von der Ohe8, T. Krause9, J. Höchstödter3, P. Hartmann1, B. Wiebe3, S. Schreiber2

1Gastroenterology Practice, Minden, Germany, 2University Medical Center Schleswig-Hostein, Campus Kiel, I. Department Internal Medicine - General Internal Medicine, Kiel, Germany, 3Competence Network IBD, Kiel, Germany, 4Gastroenterology Practice, Leipzig, Germany, 5Gastroenterology Practice, Saarbrücken, Germany, 6Gastroenterology Practice, Iserlohn, Germany, 7Gastroenterology Practice, Münster, Germany, 8Gastroenterology Practice, Herne, Germany, 9Gastroenterology Practice, Kassel, Germany

P729: Faecal calprotectin and faecal immunochemical test have different values depending on mucosal status in patients with ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

H. W. Kim*1, S. B. Park1, C. W. Choi1, D. H. Kang1, D. G. Ryu1

1Pusan National University Yangsan Hospital, Internal medicine, Yangsan, South Korea

P730: Short and long-term outcome of acute severe colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Marwa*1, M. Ghanem1

1Medical University of Tunis, Gastroenterology, Tunis, Tunisia

P731: Characteristics and follow-up on body composition, physical activity and quality of life in paediatric patients with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

K. K. Boros*1, O. Cseprekál2, K. E. Müller3, A. Dezsőfi1, G. Reusz1, G. Veres3

1Semmelweis University, Ist Department of Paediatrics, Budapest, Hungary, 2Semmelweis University, Ist Department of Medicine, Budapest, Hungary, 3University of Debrecen, Paediatric Institute-Clinic, Debrecen, Hungary

P732: Endoscopic Balloon Dilation Of Symptomatic Intestinal Crohn’s disease Strictures: Long-Term Data On Efficacy And Safety In A Cohort Of Patients Followed-up For 10 Years

ECCO '19 Copenhagen

Year: 2019
Authors:

D. Scimeca1, F. Mocciaro*1, R. Di Mitri1, M. Giunta2, S. Renna3, G. Teresi4, E. Conte1, A. Bonaccorso1, A. Casà3, M. Cottone5, A. Orlando3

1Gastroenterology and Endoscopy Unit, ARNAS Civico-Di Cristina-Benfratelli Hospital, Palermo, Italy, 2Gastroenterology Unit, Villa Sofia-Cervello Hospital, Palermo, Italy, 3IBD Unit, Villa Sofia-Cervello Hospital, Palermo, Italy, 4Internal Medicine, Villa Sofia-Cervello Hospital, Palrmo, Italy, 5Internal Medicine, Villa Sofia-Cervello Hospital, Palermo, Italy

P733: Comparative Analysis of Monotherapy and Combination Biological Therapy for Crohn’s disease and ulcerative colitis: Results from a Multi-Country Study in Europe

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Robinson*1, R. Bergman2, P. Collins1, C. Karki2, Y. Lu2

1Ipsos MORI, Global Healthcare Monitors, London, UK, 2Ipsos MORI, Global Healthcare Monitors, New York, USA